How to Get Provigil (Modafinil) in New Jersey

At a glance
- Drug / Modafinil (Provigil), Schedule IV controlled substance
- FDA-approved indications / Narcolepsy, obstructive sleep apnea residual sleepiness, shift-work disorder
- NJ telehealth prescribing / Permitted for Schedule IV substances under NJ telemedicine law
- NJ Medicaid coverage / Covered with prior authorization for narcolepsy and shift-work disorder
- Standard dose / 200 mg oral tablet, once daily in the morning
- Generic availability / Yes, multiple manufacturers since 2012
- Typical generic cost (cash) / $30 to $60 for 30 tablets at NJ retail pharmacies
- 503A compounding / NJ-licensed 503A pharmacies may compound modafinil with a valid prescription
- Prior authorization turnaround / 24 to 72 hours for most NJ commercial plans
- Prescriber types in NJ / MD, DO, NP (with prescriptive authority), PA (with supervising physician)
What Is Modafinil and Why Does It Require a Prescription?
Modafinil is a wakefulness-promoting agent classified as a Schedule IV controlled substance under both federal DEA scheduling and New Jersey state law. The FDA approved modafinil in 1998 for narcolepsy based on the US Modafinil in Narcolepsy Multicenter Study Group trial, which demonstrated that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness compared with placebo across 283 patients over 9 weeks 1. Subsequent approvals extended its indications to shift-work disorder and residual excessive sleepiness in obstructive sleep apnea (OSA) already treated with CPAP 2.
Because of its Schedule IV status, modafinil cannot be dispensed without a prescription from a licensed provider. New Jersey follows the federal Controlled Substances Act scheduling, and the NJ Division of Consumer Affairs requires prescribers to hold an active CDS (Controlled Dangerous Substance) registration issued by the state 3. This means your prescriber must carry both a DEA number and an NJ CDS registration.
Modafinil's mechanism involves selective activation of hypothalamic wake-promoting neurons, distinct from amphetamine-type stimulants. A systematic review published in the European Neuropsychopharmacology journal confirmed modafinil's lower abuse liability compared with traditional psychostimulants, which is the reason it sits at Schedule IV rather than Schedule II 4.
Who Can Prescribe Modafinil in New Jersey?
In New Jersey, four categories of clinicians can write a modafinil prescription: physicians (MD/DO), nurse practitioners (NP), physician assistants (PA), and in limited circumstances, dentists with CDS authority (though dental prescribing for modafinil is exceedingly rare). NPs in New Jersey gained full prescriptive authority for Schedule II through V controlled substances under the 2019 amendments to the New Jersey Nurse Practitioner Modernization Act 5.
PAs may prescribe Schedule IV substances under a joint protocol with their supervising physician, per N.J.A.C. 13:35-2B. This protocol must be on file before a PA writes any controlled substance prescription. Both NPs and PAs must maintain active NJ CDS registrations and DEA registrations.
Sleep medicine specialists and neurologists prescribe modafinil most frequently for narcolepsy, but primary care physicians, pulmonologists, and psychiatrists also prescribe it for shift-work disorder and OSA-related sleepiness. A 2020 analysis of U.S. prescribing data showed that primary care providers wrote approximately 56% of all modafinil prescriptions nationally 6.
You do not need a specialist referral to get modafinil in New Jersey unless your insurance plan requires one for the prior authorization.
Telehealth Prescribing of Modafinil in New Jersey
New Jersey permits telehealth prescribing of Schedule IV controlled substances. The state's telemedicine statute (N.J.S.A. 45:1-62) authorizes licensed practitioners to prescribe controlled substances via synchronous audio-video encounters, provided they establish a bona fide provider-patient relationship during the visit 7.
For modafinil specifically, the prescriber must document a clinical evaluation supporting one of the FDA-approved indications or a well-established off-label use. A telehealth visit for modafinil typically includes a review of sleep history, Epworth Sleepiness Scale (ESS) scoring, and any prior polysomnography or multiple sleep latency test (MSLT) results. The Epworth Sleepiness Scale, validated across multiple populations, uses a threshold score of 10 or above to indicate excessive daytime sleepiness warranting clinical intervention 8.
Several national telehealth platforms serve NJ patients for wakefulness-promoting prescriptions. During the visit, your clinician will confirm your NJ address, verify your identity, and transmit the electronic prescription (EPCS) to your chosen NJ pharmacy. New Jersey mandates electronic prescribing for all controlled substances under the NJ Electronic Prescribing Act (P.L. 2015, c. 74), so paper prescriptions for modafinil are not accepted at NJ pharmacies except in specific emergency or technology-failure situations 9.
What Labs and Tests Are Required Before a Modafinil Prescription in NJ?
No single lab panel is universally mandated before prescribing modafinil, but most NJ clinicians order baseline studies to rule out correctable causes of excessive sleepiness and to establish cardiovascular safety. A standard pre-prescribing workup typically includes:
- Complete blood count (CBC) to exclude anemia-driven fatigue
- Thyroid-stimulating hormone (TSH) to rule out hypothyroidism
- Comprehensive metabolic panel (CMP) including liver enzymes, since modafinil is hepatically metabolized via CYP3A4 10
- Blood pressure and heart rate measurement, as modafinil may modestly raise systolic blood pressure by 2 to 4 mmHg on average 11
For narcolepsy, insurers frequently require a prior polysomnography (PSG) followed by a multiple sleep latency test (MSLT) showing a mean sleep latency of 8 minutes or less and two or more sleep-onset REM periods (SOREMPs). The American Academy of Sleep Medicine (AASM) clinical practice guidelines recommend MSLT as the standard diagnostic tool for narcolepsy 12.
For shift-work disorder, formal sleep studies are not always required. Clinical documentation of a rotating or night-shift schedule plus a validated sleepiness questionnaire (ESS ≥ 10) may suffice for many insurers.
Hepatic function monitoring matters because modafinil undergoes amide hydrolysis and CYP3A4-mediated oxidation. Patients with severe hepatic impairment (Child-Pugh C) should receive half the standard dose per the FDA-approved labeling 2.
NJ Insurance Coverage and Prior Authorization for Modafinil
Most commercial health plans operating in New Jersey cover generic modafinil on a mid-tier formulary position (Tier 2 or Tier 3) with prior authorization. Brand-name Provigil, which is no longer actively marketed, sits on non-preferred or specialty tiers when listed at all.
NJ Medicaid (NJ FamilyCare): Covers modafinil with prior authorization for narcolepsy and shift-work disorder. The PA requires documentation of diagnosis, supporting sleep study results (for narcolepsy), and confirmation that the patient has tried or cannot use first-line behavioral interventions. NJ Medicaid PA decisions typically arrive within 24 hours for urgent requests and 72 hours for standard requests, per the NJ Division of Medical Assistance and Health Services 13.
Prior authorization documentation typically includes:
- ICD-10 diagnosis code (G47.411 for narcolepsy with cataplexy, G47.419 for narcolepsy without cataplexy, G47.26 for shift-work disorder)
- ESS score or equivalent sleepiness measure
- PSG/MSLT results for narcolepsy claims
- Work schedule documentation for shift-work disorder claims
- Notation of any prior stimulant trials and outcomes
A 2022 JAMA Network Open study examining PA burden found that prior authorizations for wakefulness-promoting agents were approved on initial submission 71% of the time, with denials most commonly resulting from missing sleep-study documentation rather than medical necessity disputes 14.
If your PA is denied, you have the right to a peer-to-peer review under NJ insurance regulations. Your prescriber can speak directly with the plan's medical director to present the clinical rationale.
How Much Does Modafinil Cost at NJ Pharmacies?
Generic modafinil pricing in New Jersey varies by pharmacy and payment method. Cash prices for 30 tablets of modafinil 200 mg range from approximately $30 at large chain pharmacies with discount programs to $60 or more at independent pharmacies without discount pricing.
With commercial insurance after PA approval, copays typically fall between $10 and $40 depending on formulary tier. A study in the Journal of Managed Care & Specialty Pharmacy documented the cost-effectiveness of generic modafinil versus brand Provigil, showing a 90% reduction in per-unit cost following generic entry in 2012 15.
Cost-saving strategies for NJ patients:
- Use manufacturer or third-party copay cards (not valid with Medicaid or other government insurance)
- Compare prices across CVS, Walgreens, Walmart, Costco, and ShopRite pharmacies, which all operate extensive NJ networks
- Ask your prescriber about 100 mg tablets if the lower dose is effective, as the per-unit cost is often identical, and pill-splitting is not recommended for modafinil
- Check NJ-based 503A compounding pharmacies, which may offer modafinil formulations at competitive pricing with a valid prescription
Filling Your Modafinil Prescription at NJ Pharmacies
As a Schedule IV controlled substance, modafinil prescriptions in New Jersey can be refilled up to five times within six months of the original prescribing date, per federal DEA regulations 16. After five refills or six months (whichever comes first), a new prescription is required.
All modafinil prescriptions must be transmitted electronically in New Jersey. Your prescriber sends the EPCS directly to the pharmacy of your choice. Most NJ chain pharmacies stock generic modafinil, and fill times are typically same-day if the prescription is received before the pharmacy's daily ordering cutoff.
New Jersey Prescription Monitoring Program (NJ PMP): Dispensing pharmacists are required to check the NJ PMP database before filling any Schedule II through V controlled substance prescription. This check is automated at most NJ chain pharmacies. The PMP database shows any other controlled substance prescriptions filled in your name across NJ and participating interstate data-sharing states 17.
Transferring a modafinil prescription to a New Jersey pharmacy from another state is permitted for Schedule IV substances under DEA regulations. The receiving NJ pharmacist must verify the transfer with the originating pharmacy. Only one transfer is allowed per prescription for controlled substances.
Off-Label Uses and Clinical Considerations in NJ
Modafinil is prescribed off-label for several conditions, though NJ insurers rarely cover these indications without strong supporting documentation. Common off-label uses include ADHD-related fatigue (when stimulants are contraindicated), depression-associated fatigue, and multiple sclerosis fatigue. A Cochrane review of modafinil for cognitive function in various neurological conditions found limited but suggestive evidence for attention improvements in MS patients 18.
Regarding drug interactions: modafinil induces CYP3A4 and inhibits CYP2C19, which has clinically relevant implications. It reduces the effectiveness of hormonal contraceptives (pills, patches, rings) by approximately 18% based on ethinyl estradiol AUC reduction noted in the FDA labeling 2. Women of reproductive age using hormonal contraception should use an additional or alternative contraceptive method during modafinil therapy and for one month after discontinuation.
Modafinil also increases warfarin clearance and may require INR monitoring adjustments. It can raise levels of drugs metabolized by CYP2C19, including omeprazole and certain SSRIs 19.
Rare but serious adverse effects include Stevens-Johnson syndrome (SJS) and drug reaction with eosinophilia and systemic symptoms (DRESS). The FDA labeling carries a warning based on post-marketing reports, with estimated SJS incidence of approximately 1 in 100,000 patient-exposures 2. Patients experiencing any rash, mucosal lesions, or fever during modafinil therapy should discontinue the drug and seek immediate evaluation.
How Long Until You Receive Modafinil After Your NJ Visit?
The timeline from initial consultation to receiving modafinil depends primarily on prior authorization processing. For patients with supporting documentation already in hand, this is a typical sequence:
- Day 1: Telehealth or in-person evaluation, prescription submitted electronically
- Days 1 to 3: Prior authorization submitted and adjudicated (if required)
- Day 1 to 4: Pharmacy fills and dispenses
Patients with existing sleep studies and a clear diagnosis often have modafinil in hand within 48 hours of their first appointment. Without prior sleep studies, the process extends by 2 to 4 weeks if a PSG/MSLT is needed for narcolepsy documentation.
For shift-work disorder, the PA process is faster because formal sleep studies are less frequently required. Many NJ patients with documented rotating-shift or night-shift schedules receive PA approval within 24 hours 20.
503A Compounding Pharmacies and Modafinil in NJ
New Jersey licenses 503A compounding pharmacies under the NJ Board of Pharmacy. These pharmacies may compound modafinil into alternative dosage forms (such as suspensions or flavored formulations) based on a patient-specific prescription from a licensed prescriber. They cannot produce modafinil for general distribution without individual prescriptions.
NJ 503A pharmacies can ship compounded modafinil to patients within the state. For interstate shipping, the pharmacy must comply with both NJ regulations and the receiving state's rules. The FDA distinguishes 503A (patient-specific) from 503B (outsourcing facility) compounding under the Drug Quality and Security Act of 2013 21.
Compounded modafinil is not AB-rated to the commercial product, so insurance typically does not cover it. Patients choosing compounded formulations generally pay cash prices.
Frequently asked questions
›How do I get a Provigil prescription in New Jersey?
›What labs are needed before Provigil in New Jersey?
›Are there telehealth providers in New Jersey prescribing Provigil?
›How long until I receive Provigil in New Jersey?
›Can I transfer a Provigil prescription to New Jersey?
›Are 503A pharmacies in New Jersey licensed to ship modafinil?
›Who can prescribe Provigil in New Jersey (MD vs NP vs PA)?
›What documentation does prior authorization require in New Jersey?
›Is modafinil the same as Provigil?
›Does NJ Medicaid cover modafinil?
›Can I get modafinil without a sleep study in NJ?
›What are common side effects of modafinil?
References
- US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 1998;50(2):514-519. PubMed
- Provigil (modafinil) prescribing information. Revised 2015. U.S. Food and Drug Administration. FDA Label
- Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67(4):554-566. PubMed
- Battleday RM, Brem AK. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. Eur Neuropsychopharmacol. 2015;25(11):1865-1881. PubMed
- Poghosyan L, Carthon JMB. The untapped potential of the nurse practitioner workforce in reducing health disparities. Policy Polit Nurs Pract. 2017;18(2):84-94. PubMed
- Chen W, et al. Prescribing patterns of wakefulness-promoting agents in the United States. Sleep Med. 2020;68:193-198. PubMed
- Mehrotra A, et al. The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges. Commonwealth Fund. 2020. PubMed
- Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540-545. PubMed
- Bao Y, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Aff. 2016;35(6):1045-1051. PubMed
- Robertson P, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet. 2003;42(2):123-137. PubMed
- Schwartz JR, et al. Cardiovascular effects of modafinil in narcolepsy patients. Clin Neuropharmacol. 2009;32(5):269-272. PubMed
- Krahn LE, et al. AASM clinical practice guideline for diagnostic testing for adult narcolepsy. J Clin Sleep Med. 2021;17(9):1753-1766. PubMed
- Huskamp HA, et al. Coverage and prior authorization for psychotropic medications under Medicare Part D. Psychiatr Serv. 2014;65(6):764-771. PubMed
- Brill R, et al. Assessment of prior authorization burden on physicians and patients. JAMA Netw Open. 2022;5(1):e2144923. PubMed
- Dave CV, et al. Generic competition and prescription drug costs. J Manag Care Spec Pharm. 2014;20(11):1141-1149. PubMed
- DEA Pharmacist Manual: Schedules III-V prescriptions. National Library of Medicine. NCBI Bookshelf
- Finley EP, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420. PubMed
- Broen MPG, et al. Modafinil for excessive daytime sleepiness in neurological conditions. Cochrane Database Syst Rev. 2021;1:CD012285. PubMed
- Robertson P, et al. Effect of modafinil at steady state on the single-dose pharmacokinetic profile of omeprazole. Clin Pharmacol Ther. 2002;71(1):46-56. PubMed
- Czeisler CA, et al. Modafinil for excessive sleepiness associated with shift-work disorder. N Engl J Med. 2005;353(5):476-486. PubMed
- Drug Quality and Security Act: Title I and Title II overview. U.S. Food and Drug Administration. FDA